Exparel for Total Shoulder Arthroplasty

PHASE4CompletedINTERVENTIONAL
Enrollment

102

Participants

Timeline

Start Date

August 12, 2020

Primary Completion Date

February 8, 2021

Study Completion Date

February 17, 2021

Conditions
Total Shoulder Arthroplasty
Interventions
DRUG

Exparel

Single shot Exparel 10cc (133mg) mixed with 10cc of 0.5% Bupivicaine

DRUG

Pain Pump

Subject will receive an interscalene block with Ropivicaine 0.5% (20cc), and then a pain pump attached in the Post Anesthesia Care Unit infusing at 4cc/hr. The patient will go home with that device until it runs out.

Trial Locations (1)

40202

Norton Healthcare, Louisville

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Norton Healthcare

OTHER

NCT04364867 - Exparel for Total Shoulder Arthroplasty | Biotech Hunter | Biotech Hunter